跳至主要内容
临床试验/KCT0004614
KCT0004614招募中未知

Comparison of activity levels of cytokine in serum of patient with pancreatic cancer, patient with other cancers (cholangiocarcinoma, stomach cancer, liver cancer, colorectal cancer, lung cancer), high risk for pancreatic cancer and benign pancreatic disease and healthy control and validation of clinical effects, pilot study

Yonsei University Health System, Gangnam Severance Hospital0 个研究点目标入组 510 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
510

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational Study

入排标准

年龄范围
19(Year) 至 90(Year)(—)
性别
All

入选标准

  • 1. Pancreatic cancer
  • 1). Patients with pancreatic cancer confirmed by imaging (CT, MRI, PET-CT)
  • 2). Patients with pancreatic cancer diagnosed using cytology by endoscopic ultrasound
  • 3). Patients who underwent surgical treatment with pancreatic cancer
  • 2. Patients with other carcinomas (biliary cancer, stomach cancer, liver cancer, colon cancer, lung cancer)
  • 1) Biliary cancer: Patients suspected of biliary tract cancer by imaging tests (CT, MRI, PET-CT) and biliary endoscopic examination and confirmed biliary tract cancer by tissue or cytology examination
  • 2) Stomach cancer: Patients suspected of stomach cancer by imaging tests (CT, MRI, PET-CT) and endoscopic examination and confirmed stomach cancer by tissue or cytology examination
  • 3) Liver cancer: Patients suspected of liver cancer by imaging tests (CT, MRI, PET-CT) and confirmed liver cancer by tissue or cytology examination
  • 4) Colorectal cancer: Patients with colorectal cancer suspected by imaging tests (CT, MRI, PET-CT), and colonoscopy and confirmed colorectal cancer by tissue or cytology examination
  • 5) Lung cancer: Patients whose lung cancer is suspected by imaging tests by imaging tests (X-ray, CT, MRI, PET-CT), sputum cell test, and bronchoscope and confirmed lung cancer by tissue or cytology examination
  • 3. Patients with high risk for pancreatic cancer
  • Patient diagnosed with ? chronic pancreatitis ? pancreatic cyst ? benign pancreatic mass ? pancreatic duct dilatation by imaging studies (US, CT, MRI) ? Patients diagnosed with diabetes within two years of age 55 and older ? Patients with elevated CA 19-9 levels (50U / mL or higher; normal reference value: 0.8-24 U / mL)
  • 4. Patients with benign pancreatic disease
  • Patient diagnosed with acute pancreatitis
  • 5. healthy control
  • Those who have not been diagnosed with malignant or pancreatic diseases through a medical examination within 6 months of the decision to participate in the study

排除标准

  • 1. Minors under the age of 19, vulnerable subjects such as illiteracy
  • 2. Those who have received immunosuppressive drugs from past medical history

研究者

发起方
Yonsei University Health System, Gangnam Severance Hospital

相似试验